4 | SEC Filings Hub

Filing metadata

Accession number: 0001628280-22-005130
Form type: Form 4
Filer: Aurinia Pharmaceuticals Inc.
CIK: CIK 1600620
Filed: Mar 04, 2022
Reporting period: Mar 02, 2022
Description: Insider transaction

Documents

0001628280-22-005130-index.htm

Complete submission

0001628280-22-005130.txt

directory listing

Filed by

Aurinia Pharmaceuticals Inc.